ロード中...
Duloxetine versus ‘active’ placebo, placebo or no intervention for major depressive disorder; a protocol for a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis
BACKGROUND: Major depression significantly impairs quality of life, increases the risk of suicide, and poses tremendous economic burden on individuals and societies. Duloxetine, a serotonin norepinephrine reuptake inhibitor, is a widely prescribed antidepressant. The effects of duloxetine have, howe...
保存先:
| 出版年: | Syst Rev |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2021
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8191126/ https://ncbi.nlm.nih.gov/pubmed/34108032 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13643-021-01722-5 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|